XML 40 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity (Deficiency) (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Jan. 31, 2013
Dec. 31, 2012
Mar. 31, 2012
Dec. 31, 2014
Dec. 31, 2017
Dec. 31, 2016
Company issued warrants to purchase unregistered shares of the Company's common stock 400,000   75,000 325,000        
Exercise price per share in association with stock subscription agreements $ 0.21   $ 0.41 $ .40        
Warrants expiration date     Dec. 31, 2018 Dec. 31, 2017        
Company issued its Chief Executive Officer five year warrants to purchase common stock   1,000,000         25,000 25,000
Company issued its Chief Financial Officer five year warrants to purchase common stock   500,000           25,000
Company recognized an amount in compensation expense   $ 210,000         $ 25,000  
Exercise price per share in association with stock issued to Chief Executive Officer and Chief Financial Officer   $ 0.30            
Extending maturity date          

the Company revised the terms of the 400,000 original warrants issued December 2012 and January 2013, extending the maturity dates to December 31, 2017 and the exercise price was reduced from $0.41 per share to $0.39 per share. The Company also revised the terms of the additional 400,000 warrants issued December 1, 2013, to extend the maturity date to December 31, 2018 and the exercise price was reduced from $0.21 per share to $0.17 per share.

    
Warrants outstanding             800,000  
Warrants Epxpired             1,055,000  
Maximum [Member]                
Exercise price per share in association with stock subscription agreements         $ 2.00      
Minimum [Member]                
Exercise price per share in association with stock subscription agreements         $ 4.00